ResearcherCentral South UniversityActive in the last 2 years
Mujing Ke
Matched on ORCID iD 0000-0001-5428-4115; OpenAlex author ID A5030457314, A5120993846. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Integrated in vivo and in vitro experiments with multi-omics analysis reveal SPP1 drives pancreatic cancer progression. Co-author DOI 10.1186/s12885-026-15659-2↗
- Systematic Analysis of Molecular Subtypes Based on the Expression Profile of Immune-Related Genes in Pancreatic Cancer. Co-author DOI 10.1155/2022/3124122↗
- Identification and Validation of Apparent Imbalanced Epi-lncRNAs Prognostic Model Based on Multi-Omics Data in Pancreatic Cancer. Co-author DOI 10.3389/fmolb.2022.860323↗
- Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer. Co-author DOI 10.1186/s12935-020-01474-7↗
- [Current consensus and controversy in neoadjuvant therapy for pancreatic cancer]. Last author DOI 10.3760/cma.j.issn.0529-5815.2020.02.005↗
- miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn. Co-author DOI 10.1016/j.biopha.2018.06.114↗
- MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9. Co-author DOI 10.3892/mmr.2015.3294↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yixiong Li · 3 shared papers, 2018–2020 · strength 0.45
- Paper Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer. DOI 10.1186/s12935-020-01474-7↗
- Paper [Current consensus and controversy in neoadjuvant therapy for pancreatic cancer]. DOI 10.3760/cma.j.issn.0529-5815.2020.02.005↗
- Paper miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn. DOI 10.1016/j.biopha.2018.06.114↗
- Zhenglin Ou · 2 shared papers, 2018–2020 · strength 0.26
- Neng Tang · 1 shared paper, 2018 · strength 0.10
- Guodong Liu · 1 shared paper, 2018 · strength 0.10
- LI Yi-xiong · 1 shared paper, 2015 · strength 0.06
- Xiaoping Yi · 1 shared paper, 2015 · strength 0.06
- Bo Liu · 1 shared paper, 2015 · strength 0.06
- Tong Han · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.